Get ready for a fun night out for our inaugural ‘Rockstars Of Research’ – Cure Parkinson’s NZ event at the Bay Oval in Mount Maunganui on 31st July 2025!
Help us raise $100,000 for another research rockstar to join our special team of scientists – Our ‘Cure Collective’.
The Evening Will Feature:
– Sponsorship opportunities to showcase your brand as a supporter of Cure Parkinson’s NZ.
– Live auctions.
– Our fabulous MC – Seamus Marten from ‘Between Two Beers’.
– ‘Research Rockstart’ Q&A with Professor, Maurice Curtis (The Cure Collective) and Tony Egan (Greenlea Meats and Parkinson’s sufferer).
– A very special performance by Jason Kerrison – NZ singer-songwriter, best known as the frontman for Kiwi band Opshop.
– Additional entertainment from Josh Leys – Kiwi entertainer and finalist in Timbaland’s current global talent search.
Check out the latest in Parkinson’s research as well as what we and our supporters have been getting up to.
More News
We discuss evidence linking Parkinson’s disease to environmental factors including pesticides, chemicals, and air pollution, in an editorial that featured in the May 19, 2025 edition of Farmer’s Weekly.
Read More
Join us on July 31, 2025, at Bay Oval in Mount Maunganui and help us raise $100,000 for another research rockstar!
Read More
A recently completed clinical trial reveals promise for the strategy of immunosuppression for slowing Parkinson’s progression
Read More
Watch the Q&A with acclaimed NZ film and TV director Toa Fraser at our Cup for a Cure launch event here.
Read More
Exciting outcomes from Cure Parkinson’s NZ-funded research.
Read More
CEO Daniel attends international meetings with partner organisations.
Read More
A phase 2 study of the GLP-1R agonist lixisenatide in people with early-stage Parkinson’s, conducted in France, is reported in the New England Journal of Medicine.
Read More
NZ news media interviewed our CEO on World Parkinson’s Day as we launched our documentary One in 37 and discussed global collaborations as we work toward a cure.
Read More
Prestigious British medical journals provide a state of play on Parkinson’s research and ask “what next”?
Read More
The US Federal Government may soon be joining the team as the urgent need for research leading to prevention and a cure gains support in high places.
Read More
A 62-year-old man with late-stage Parkinson’s and severe gait impairments regains the ability to walk normally following experimental treatment in Switzerland.
Read More
While most of the country was watching the RWC final live, our small team of CPNZ athletes blitzed the Auckland Harbour Bridge in blustery conditions at the 2023 Auckland Marathon.
Read More
Could wearable devices one day be used to predict who might go on to receive a Parkinson’s diagnosis? Quite possibly. Machine learning models fed movement data recently did just that.
Read More
Distinguished Professor Sir Richard Faull, Trustee of Cure Parkinson’s NZ, likens our NZ brain researchers to the All Blacks.
Read More
Trustee Marise Winthrop shares her thoughts on the importance of our work toward a cure for Parkinson’s.
Read More
Supporter David Kidd, a UK-based kiwi living with Parkinson’s, shared this poignant, beautiful and brilliantly optimistic video with us for screening at our recent fundraising dinner.
Read More
Our CEO Daniel McGowan recently spent an hour in the studio with host Tim Beveridge on his 1ZB radio show “The Weekend Collective”.
Read More
Our CEO Daniel McGowan recently travelled to the UK and Europe bringing back the latest research updates and forming some strong connections.
Read More
New biomarker enables accurate biochemical diagnosis of very early-stage Parkinson’s disease, ushering in a new era of clinical trials for Parkinson’s better geared for success.
Read More
Could a cough medication really stop or slow Parkinson’s progression? A trial getting underway this year will provide the answer.
Read More
Rob Spear and Sam Paterson really dug deep to raise funds for Cure Parkinson’s NZ in February as they completed the two-day tandem Coast to Coast Challenge raising >$26,000.
Read More
On February 10 our CEO Daniel visited the NZ Brain Research Institute and BrainTree Wellness Centre in Christchurch.
Read More
We are very grateful to the Greenlea family and their Greenlea Foundation Trust for the generous donation of $100,000 for Parkinson’s research in December 2022.
Read More
When we talk about finding a cure for Parkinson’s, what does that mean? Will there be a “silver bullet” treatment? Probably not, but there is good cause for hope.
Read More
Cure Parkinson’s in the UK are at the core of global efforts to fight this awful disease, and we were thrilled to establish a partnership with them in October 2022.
Read MoreOur 60-min documentary tells the personal stories of five individuals living with Parkinson’s disease and highlights the New Zealand research effort to develop therapies that can stop or slow disease progression. It also breaks down some of the myths and misunderstandings surrounding Parkinson’s disease. A cure is a very real possibility, it is just a matter of when.
We’re very proud of this film, and extremely grateful to all those involved in sharing their personal stories to help educate other New Zealanders on this emerging pandemic. Help us to accelerate the timeframe towards a cure by joining us in our mission and supporting research done the Kiwi way because sadly their stories may also become your story.
Watch DocumentaryGrowing out of Neuro Research Charitable Trust, which was founded by Bernie and Kaye Crosby in 2013, Cure Parkinson’s NZ is led by an experienced management team supported by a dedicated Board of Trustees, an international Scientific Advisory Council, and a volunteer fundraising committee.
Meet Our TeamThis insidious disease, which slowly robs sufferers of their abilities to move, think and perform everyday tasks, affects >12,000 New Zealanders and more than 10 million people worldwide. Prevalence is expected to double in the next 10–15 years.
Current treatments can only relieve symptoms; none can slow or stop the progression of the disease. However, new knowledge about Parkinson’s disease processes has led to the discovery of some promising candidate treatments with the potential to stop or slow disease progression. Now, clinical trials and further research are urgently needed to confirm benefits and get these treatments approved and into the hands of patients.
The research required to get promising treatments to the clinic is expensive. But the cost to patients, their families, healthcare systems, and economies of not doing this research is much much more. We need your support to make it happen.
